Literature DB >> 18005785

Factors influencing the number of sentinel lymph nodes identified in patients with breast cancer.

Anees B Chagpar1, David J Carlson, Alison L Laidley, Souzan E El-Eid, Terre Q McGlothin, Robert D Noyes, Phillip B Ley, Todd M Tuttle, Kelly M McMasters.   

Abstract

BACKGROUND: Although the sentinel lymph node (SLN) is defined as the first node draining a tumor, multiple nodes are often identified. Few SLNs are required for adequate staging; removal of more may be unnecessary. The objective of this study was to determine factors influencing the number of SLN identified.
METHODS: The University of Louisville Breast Sentinel Lymph Node Study was used to determine correlates of identifying greater than 4 SLNs by using univariate and multivariate analyses.
RESULTS: An SLN was identified in 3,882 of 4,131 patients (94%). The median number of SLN identified was 2 (range 1-18); 90% had < or = 4 SLNs identified. Palpable tumors, surgeon inexperience, and dermal injection were associated with greater than 4 SLNs identified. All 3 of these factors remained significant on multivariate analysis.
CONCLUSIONS: Palpable tumors often have greater than 4 SLNs identified, and the use of intradermal injection increases this probability.

Entities:  

Mesh:

Year:  2007        PMID: 18005785     DOI: 10.1016/j.amjsurg.2007.08.024

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  5 in total

1.  Do the ACOSOG Z0011 Criteria Affect the Number of Sentinel Lymph Nodes Removed?

Authors:  Preeti Subhedar; Michelle Stempel; Anne Eaton; Monica Morrow; Mary L Gemignani
Journal:  Ann Surg Oncol       Date:  2015-07-16       Impact factor: 5.344

2.  Optimal number of radioactive sentinel lymph nodes to remove for accurate axillary staging of breast cancer.

Authors:  Melanie A Lynch; Jeshaun Jackson; Julian A Kim; Rosemary A Leeming
Journal:  Surgery       Date:  2008-08-10       Impact factor: 3.982

3.  Sentinel node biopsy for breast cancer patients: issues for discussion and our practice.

Authors:  Georgios Pechlivanides; Dorothy Vassilaros; Anastasios Tsimpanis; Anastasia Apostolopoulou; Stamatis Vasilaros
Journal:  Patholog Res Int       Date:  2010-12-28

4.  Comparison of [(99m)Tc]tilmanocept and filtered [(99m)Tc]sulfur colloid for identification of SLNs in breast cancer patients.

Authors:  Jennifer L Baker; Minya Pu; Christopher A Tokin; Carl K Hoh; David R Vera; Karen Messer; Anne M Wallace
Journal:  Ann Surg Oncol       Date:  2014-07-29       Impact factor: 5.344

5.  Decreased Survival of Invasive Ductal Breast Cancer Patients With Two Macrometastatic Lymph Nodes Among Few Resected Ones: Should Current Sentinel-Lymph-Node Guidelines Be Revised?

Authors:  Felipe A C Luz; Rogério A Araújo; Marcelo J B Silva
Journal:  Front Oncol       Date:  2021-07-19       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.